With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Gilead Sciences is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV ...

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is blaming government funding ...

French biotech OSE Immunotherapeutics is taking charge of a new project aimed at fast-tracking nanodrug development and ...